Ovid Therapeutics Inc. (OVID) SEC filings
OVID SEC filings moved a median of -0.56% by the close. OVID SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the OVID overview →
66 measured OVID SEC filing events.
Where these OVID SEC filings landedvs 66 measured OVID SEC filing reactions
| Middle 50% of OVID SEC filing reactions | -4.46% to +3.52% |
|---|---|
| Median reaction (to close) | -0.56% |
| Measured reactions | 66 |
Point-in-time · zero look-ahead
Half of the 66 OVID SEC filing events with a measured close landed between -4.46% and +3.52%; 47% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Ovid Therapeutics Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.38% | +5.66% | |
| Form 8-K Ovid Therapeutics Inc. For: Aug 11 | SEC filing · Form 8-K | -0.38% | +5.66% | |
| Form 8-K Ovid Therapeutics Inc. For: Jul 05 | SEC filing · Form 8-K | -1.12% | +1.87% | |
| Form 8-K Ovid Therapeutics Inc. For: Jun 11 | SEC filing · Form 8-K | -1.10% | -3.07% | |
| Form 8-K Ovid Therapeutics Inc. For: May 29 | SEC filing · Form 8-K | -1.60% | +0.42% | |
| Form 10-Q Ovid Therapeutics Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.44% | +3.24% | |
| Form 8-K Ovid Therapeutics Inc. For: May 12 | SEC filing · Form 8-K | -1.44% | +3.24% | |
| Form ARS Ovid Therapeutics Inc. For: Dec 31 | SEC filing · Form ARS | +1.30% | +0.37% | |
| Form DEF 14A Ovid Therapeutics Inc. For: Dec 31 | SEC filing · Form DEF | +1.30% | +0.37% | |
| Form DEFA14A Ovid Therapeutics Inc. | SEC filing · Form DEFA14A | +1.30% | +0.37% | |
| Form EFFECT Ovid Therapeutics Inc. | SEC filing · Form EFFECT | +1.94% | +4.26% | |
| Form S-3 Ovid Therapeutics Inc. | SEC filing · Form S-3 | +0.17% | -7.32% | |
| Form 8-K Ovid Therapeutics Inc. For: Apr 17 | SEC filing · Form 8-K | -1.38% | -0.34% | |
| Form 10-K Ovid Therapeutics Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.44% | |
| Form 8-K Ovid Therapeutics Inc. For: Mar 17 | SEC filing · Form 8-K | -3.35% | -3.77% | |
| Form S-8 Ovid Therapeutics Inc. | SEC filing · Form S-8 | +0.00% | +0.44% | |
| Form EFFECT Ovid Therapeutics Inc. | SEC filing · Form EFFECT | -1.20% | +3.43% | |
| Form 8-K Ovid Therapeutics Inc. For: Dec 18 | SEC filing · Form 8-K | +1.48% | -0.74% | |
| Form S-3 Ovid Therapeutics Inc. | SEC filing · Form S-3 | +2.94% | +1.31% | |
| Form 8-K Ovid Therapeutics Inc. For: Dec 11 | SEC filing · Form 8-K | +0.92% | +1.23% | |
| Form 10-Q Ovid Therapeutics Inc. For: Sep 30 | SEC filing · Form 10-Q | +5.90% | +8.20% | |
| Form 8-K Ovid Therapeutics Inc. For: Nov 12 | SEC filing · Form 8-K | +5.90% | +8.20% | |
| Form DEF 14A Ovid Therapeutics Inc. For: Dec 11 | SEC filing · Form DEF | -2.26% | -0.75% | |
| Form PRE 14A Ovid Therapeutics Inc. For: Dec 11 | SEC filing · Form PRE | -2.50% | -6.88% | |
| Form PREM14A Ovid Therapeutics Inc. For: Dec 11 | SEC filing · Form PREM14A | -2.50% | -6.88% | |
| Form 8-K Ovid Therapeutics Inc. For: Oct 02 | SEC filing · Form 8-K | -2.15% | -3.76% | |
| Form 8-K Ovid Therapeutics Inc. For: Sep 11 | SEC filing · Form 8-K | -1.09% | -10.94% | |
| Form 10-Q Ovid Therapeutics Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.19% | +52.62% | |
| Form 8-K Ovid Therapeutics Inc. For: Aug 13 | SEC filing · Form 8-K | -1.19% | +52.62% | |
| Form 8-K Ovid Therapeutics Inc. For: Jul 10 | SEC filing · Form 8-K | -4.08% | -8.16% | |
| Form 8-K Ovid Therapeutics Inc. For: Jun 25 | SEC filing · Form 8-K | -7.57% | -0.79% | |
| Form ARS Ovid Therapeutics Inc. For: Dec 31 | SEC filing · Form ARS | -3.08% | -4.43% | |
| Form DEF 14A Ovid Therapeutics Inc. For: Dec 31 | SEC filing · Form DEF | -3.08% | -4.43% | |
| Form DEFA14A Ovid Therapeutics Inc. | SEC filing · Form DEFA14A | -3.08% | -4.43% | |
| Form 10-Q Ovid Therapeutics Inc. For: Mar 31 | SEC filing · Form 10-Q | -6.73% | -13.33% | |
| Form 8-K Ovid Therapeutics Inc. For: May 13 | SEC filing · Form 8-K | -6.73% | -13.33% | |
| Form 8-K Ovid Therapeutics Inc. For: May 01 | SEC filing · Form 8-K | +0.00% | -4.48% | |
| Form PRE 14A Ovid Therapeutics Inc. For: Apr 24 | SEC filing · Form PRE | +0.00% | -4.48% | |
| Form 10-K/A Ovid Therapeutics Inc. For: Dec 31 | SEC filing · Form 10-K | -2.45% | -8.21% | |
| Form 10-K Ovid Therapeutics Inc. For: Dec 31 | SEC filing · Form 10-K | -1.96% | -3.92% | |
| Form 8-K Ovid Therapeutics Inc. For: Mar 10 | SEC filing · Form 8-K | -1.96% | -3.92% | |
| Form 8-K Ovid Therapeutics Inc. For: Mar 01 | SEC filing · Form 8-K | +3.00% | +3.72% | |
| Form 8-K Ovid Therapeutics Inc. For: Feb 10 | SEC filing · Form 8-K | +0.74% | -0.95% | |
| Form 10-Q Ovid Therapeutics Inc. For: Sep 30 | SEC filing · Form 10-Q | -3.80% | -10.14% | |
| Form 8-K Ovid Therapeutics Inc. For: Nov 12 | SEC filing · Form 8-K | -3.80% | -10.14% | |
| Form 8-K Ovid Therapeutics Inc. For: Sep 08 | SEC filing · Form 8-K | +0.00% | +0.91% | |
| Form 10-Q Ovid Therapeutics Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.69% | +4.57% | |
| Form 8-K Ovid Therapeutics Inc. For: Aug 13 | SEC filing · Form 8-K | +0.69% | +4.57% | |
| Form 8-K Ovid Therapeutics Inc. For: Jul 30 | SEC filing · Form 8-K | -6.24% | +3.56% | |
| Form 8-K Ovid Therapeutics Inc. For: Jul 01 | SEC filing · Form 8-K | +1.10% | +18.11% | |
| Form 8-K Ovid Therapeutics Inc. For: Jun 27 | SEC filing · Form 8-K | +1.10% | +18.11% | |
| Form 8-K Ovid Therapeutics Inc. For: Jun 17 | SEC filing · Form 8-K | -1.77% | -28.22% | |
| Form 8-K Ovid Therapeutics Inc. For: Jun 06 | SEC filing · Form 8-K | +0.34% | +5.08% | |
| Form 10-Q Ovid Therapeutics Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.36% | +7.67% | |
| Form 8-K Ovid Therapeutics Inc. For: May 14 | SEC filing · Form 8-K | +0.36% | +7.67% | |
| Form S-8 Ovid Therapeutics Inc. | SEC filing · Form S-8 | +0.92% | +1.84% | |
| Form ARS Ovid Therapeutics Inc. For: Apr 24 | SEC filing · Form ARS | +0.00% | -4.47% | |
| Form DEF 14A Ovid Therapeutics Inc. For: Apr 24 | SEC filing · Form DEF | +0.00% | -4.47% | |
| Form DEFA14A Ovid Therapeutics Inc. | SEC filing · Form DEFA14A | +0.00% | -4.47% | |
| Form 10-K Ovid Therapeutics Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -1.28% | |
| Form 8-K Ovid Therapeutics Inc. For: Mar 08 | SEC filing · Form 8-K | +0.00% | -1.28% | |
| Form 8-K Ovid Therapeutics Inc. For: Dec 04 | SEC filing · Form 8-K | -0.68% | +4.60% | |
| Form EFFECT Ovid Therapeutics Inc. | SEC filing · Form EFFECT | +0.00% | -1.21% | |
| Form 10-Q Ovid Therapeutics Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -0.56% | |
| Form 8-K Ovid Therapeutics Inc. For: Nov 03 | SEC filing · Form 8-K | +0.00% | -0.56% | |
| Form S-3 Ovid Therapeutics Inc. | SEC filing · Form S-3 | -0.56% | -9.47% |
Keep exploring
More OVID: earnings → · analyst actions → · OVID overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Lixte Biotechnology Holdings, Inc. (LIXT) | 239 | 0.00% | 48% |
| MeiraGTx Holdings plc - Ordinary Shares (MGTX) | 239 | -0.10% | 46% |
| Cyclacel Pharmaceuticals, Inc. (CYCC) | 238 | -0.21% | 42% |
| RESTORBIO (TORC) | 238 | -0.17% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.